ACTA1 and Peritoneal Fibrosis: Additionally, it is interesting to mention that CHX intraperitoneal injection has been reported as the most commonly used method to create a peritoneal fibrosis animal model showing increased expression of transforming growth factor β1 (TGF- β1), αSMA, type I collagen, and vascular endothelial growth factor (VEGF) [50].